MKI67 and breast carcinoma: The 5-year overall survival rate of weakly stained Ki-67 breast cancer patients (≤25%) was significantly greater (93%) than the OS rate of the Ki-67 positive (>25%) breast cancer patients (82%) (Log-rank P = 0.022).